Palomar Offers New Skin Rejuvenation Platform and Announces the First FDA Clearance for Combination Fractional Resurfacing
January 18 2011 - 7:00AM
Palomar Medical Technologies, Inc., a leading researcher and
developer of lasers and pulsed-light systems for aesthetic
treatments, is pleased to announce that the Artisan™ Aesthetic
System is now being shipped. The Artisan provides a combined
fractional ablative and fractional non-ablative laser skin
resurfacing treatment – the first approach of this kind to receive
clearance by the United States Food and Drug Administration.
The Artisan Aesthetic System includes a 1540 nm or 1440 nm
non-ablative fractional laser and a 2940 nm ablative fractional
laser for skin resurfacing and a MaxG™ optimized light handpiece
for the treatment of pigmented and vascular lesions. Palomar's new
FDA clearance covers the combination use of both the non-ablative
and ablative fractional lasers during the same treatment session.
Palomar believes that this specific collection of skin resurfacing
and photofacial technologies allows practitioners to tailor a
complete skin rejuvenation regimen for each individual client.
"Artisan combines the best of our non-ablative and ablative
fractional laser technologies with our optimized light technology.
This combination of technologies can be used to improve skin tone
and texture, along with specific laser treatments for wrinkles,
scars, and stretch marks. Practitioners now have the multiple
technologies they need for an overall best-in-class treatment
depending on each individual client's age, skin condition, and
downtime preference," said Joseph P. Caruso, Palomar's President
and Chief Executive Officer.
Palomar's unique combination ablative and non-ablative
fractional treatment provides a direct benefit to clients. Arielle
Kauvar, MD, director of New York Laser and Skin Care, said, "What
is special about Artisan is that I customize just the right amount
of ablative or non-ablative fractional treatment to fit each
patient's needs for facial rejuvenation, as each patient has
different preferences for speed of treatment, downtime, and the
number of treatments they're willing to undergo. With Artisan, I
can also treat the many patients who have scars and stretch marks."
In 2009, Palomar received the first FDA clearance for the treatment
of stretch marks using a fractional laser.
"Our goal is to ensure our customers can access our leading
technology with packaging and pricing programs that best fit their
financial needs. No other aesthetic system provides so many
superior technologies for facial rejuvenation in one package,
cost-effectively," said Mr. Caruso. "Palomar continues to
offer product configurations that fit into today's economy.
Aesthetic providers now have the ability to match our technology to
fit not only their clinical needs, but their financial constraints
as well," continued Paul S. Weiner, Senior Vice-President, Chief
Financial Officer, and Treasurer.
To learn more about the Artisan Aesthetic System, and Palomar's
unique FDA clearance for a combination fractional resurfacing
treatments, please visit http://www.palomarmedical.com.
About Palomar Medical Technologies, Inc.:
Palomar is a leading researcher and developer of light-based
systems for aesthetic treatments.
Palomar pioneered the optical hair removal field, when, in 1997,
it introduced the first high-powered laser hair removal system.
Since then, many of the major advances in light-based hair removal
have been based on Palomar technology.
As a pioneer of fractional technology, Palomar is an owner of
fundamental intellectual property in this area. In December 2009,
Palomar received the first FDA clearance for the treatment of
stretch marks using a fractional non-ablative laser. In September
2010, Palomar received the first FDA clearance for a fractional
ablative and fractional non-ablative combination treatment.
In December 2006, Palomar became the first company to receive a
510(k) over-the-counter (OTC) clearance from the United States Food
and Drug Administration (FDA) for a new, patented, home-use,
light-based hair removal device. In June 2009, Palomar became the
first company to receive a 510(k) OTC clearance from the FDA for a
new, patented, home-use, laser device for the treatment of
periorbital wrinkles. OTC clearance allows the product to be
marketed and sold directly to consumers without a prescription.
There are now millions of light-based aesthetic procedures
performed around the world every year in physician offices,
clinics, spas and salons. Palomar is testing many new and
exciting applications to further advance the aesthetic market and
other surgical applications.
For more information on Palomar and its products, visit
Palomar's website at www.palomarmedical.com.
CONTACT: Branden Morris
Palomar Medical Technologies, Inc.
(781) 993-2452
bmorris@palomarmedical.com
Palomar Medical Technologies, Inc. (MM) (NASDAQ:PMTI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Palomar Medical Technologies, Inc. (MM) (NASDAQ:PMTI)
Historical Stock Chart
From Jul 2023 to Jul 2024